Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol. - Sitbon,O.; McLaughlin,V.V.; Badesch,D.B. (Thorax, 2005)